1. Schöfer H, Simonsen L. Fusidic acid in dermatology: an updated review. Eur J Dermatol. 2010. 20:6–15.
2. Kim CS, Kim TH, Park TH, Yoo JH, Kim KJ. A case of allergic contact dermatitis to sodium fusidate. Ann Dermatol. 2005. 17:95–97.
3. Bobadilla-González P, García-Menaya JM, Cordobés-Durán C, Pérez-Rangel I, Sánchez-Vega S. Generalized urticaria to fusidic acid. Allergy. 2009. 64:817–818.
4. Baptista A, Barros MA. Contact dermatitis from sodium fusidate. Contact Dermatitis. 1990. 23:186–187.
5. Hogan DJ. Widespread dermatitis after topical treatment of chronic leg ulcers and stasis dermatitis. CMAJ. 1988. 138:336–338.
6. Kraus CN, Burnstead BW. The safety record of fusidic acid in non-US markets: a focus on skin infections. Clin Infect Dis. 2011. 52:Suppl 7. S527–S537.
7. Christiansen K. Fusidic acid adverse drug reactions. Int J Antimicrob Agents. 1999. 12:Suppl 2. S3–S9.
8. Mahaur B, Sharma V, Kumar B, Kaur S. Prevalence of contact hypersensitivity to common antiseptics, antibacterials and antifungals in normal persons. Indian J Dermatol Venereol Leprol. 1987. 53:269–272.
9. Morris SD, Rycroft RJ, White IR, Wakelin SH, McFadden JP. Comparative frequency of patch test reactions to topical antibiotics. Br J Dermatol. 2002. 146:1047–1051.
10. Cronin H, Mowad C. Anaphylactic reaction to bacitracin ointment. Cutis. 2009. 83:127–129.
11. Lin FL, Woodmansee D, Patterson R. Near-fatal anaphylaxis to topical bacitracin ointment. J Allergy Clin Immunol. 1998. 101:136–137.
12. Greenberg K, Espinosa J, Scali V. Anaphylaxis to topical bacitracin ointment. Am J Emerg Med. 2007. 25:95–96.
13. Sharif S, Goldberg B. Detection of IgE antibodies to bacitracin using a commercially available streptavidin-linked solid phase in a patient with anaphylaxis to triple antibiotic ointment. Ann Allergy Asthma Immunol. 2007. 98:563–566.
14. Jacob SE, James WD. From road rash to top allergen in a flash: bacitracin. Dermatol Surg. 2004. 30:521–524.